Interferon-γ inhibition attenuates lethality after cecal ligation and puncture in rats: Implication of high mobility group box-1

Shock

Volumn 24, Issue 4, 2005, Pages 396-401

  Yin, Kingsley ^a   Gribbin, Elizabeth ^a   Wang, Haichao ^b  

^a UMDNJ School of Osteopathic Medicine   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Cytokines; Immunomodulation; Inflammation; Sepsis; Survival

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; FIBRIN DEPOSITION; HISTOLOGY; HOST RESISTANCE; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MALE; NONHUMAN; PERITONEAL FLUID; PERITONITIS; PROTEIN SECRETION; RAT; SEPSIS; TISSUE REPAIR;

ANIMALS; BLOTTING, WESTERN; CECUM; HMGB1 PROTEIN; INFLAMMATION; INTERFERON TYPE II; LIGATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; TIME FACTORS; WOUND HEALING;

EID: 26244456123     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000175556.03300.c6     Document Type: Article

References (33)

1. Echtenacher B, Freudenberg MA, Jack RS, Mannel DN: Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect Immun 69:7271-7276, 2001.
2. Hotchkiss RS, Chang KC, Grayson MH, Tinsley KW, Dunne BS, Davis CG, Osborne DF, Karl IE: Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc Natl Acad Sci USA 100:6724-6729, 2003.
3. Kohler J, Heumann D, Garotta G, Leroy D, Bailat S, Barras C, Baumgartner J-D, Glauser MP: IFN-γ involvement in the severity of Gram-negative infections in mice. J Immunol 151:916-921, 1993.
4. Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA: Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor. J Immunol 149:1666-1670, 1992.
5. Car BD, Eng VM, Schnyder B, Ozmen L, Huang S, Gallay P, Heumann D, Aguet M, Ryffel B: Interferon-γ receptor deficient mice are resistant to endotoxic shock. J Exp Med 179:1437-1444, 1994.
6. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W: Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat Med 3:678-681, 1997.
7. Miles RH, Paxton TP, Dries DJ, Gamelli RL: Interferon-γ increases mortality following cecal ligation and puncture. J Trauma 36:607-611, 1994.
8. Keller R, Joller P, Keist R, Binz H, van der Meide PH: Modulation of major histocompatibility complex (MHC) expression by interferons and microbial agents. Scand J Immunol 28:113-121, 1988.
9. Nathan CF, Murray HW, Wiebe ME, Rubin BY: Identification and interferon-g as the lymphokine that activates human macrophage oxidation metabolism and anti-microbial activity. J Exp Med 158:670-689, 1983.
10. Torrico F, Heremans H, Rivera MT, Van Marck E, Billiau A, Curlier Y: Endogenous IFN-γ is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol 146:3626-3632, 1991.
11. Miles RH, Paxton TP, Zacheis D, Dries DJ, Gamelli RL: Systemic administration of interferon-γ impairs wound healing. J Surg Res 56:288-294, 1994.
12. Gurujeyalakshmi G, Giri SN: Molecular mechanisms of antifibrotic effect of interferon-γ in bleomycin-mouse model of lung fibrosis: down-regulation of TGF-β and procollagen I and III gene expression. Exp Lung Res 21:791-794, 1995.
13. Qiu G, Gribbin E, Harrison K, Sinha N, Yin K: Inhibition of γ-interferon decreases bacterial load in peritonitis by accelerating peritoneal fibrin deposition and tissue repair. Infect Immun 71:2766-2774, 2003.
14. Czura CJ, Tracey KJ: Targeting high mobility group box 1 as a late-acting mediator of inflammation. Crit Care Med 31:S46-S50, 2003.
15. Andersson U, Wang H, Palmblad K, Aveberger A, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ: High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192:565-570, 2000.
16. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ: HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251, 1999.
17. Wang H, Yang H, Czura CJ, Sama AE, Tracey KJ: HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 164:1768-1773, 2001.
18. Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, Czura CJ, Fink MP, Tracey KJ: Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA 99:12351-12356, 2002.
19. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, Czura CJ, Wang H, Roth J, Warren HS, Fink MP, Fenton MJ, Andersson U, Tracey KJ: Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 101:296-301, 2004.
20. Rendon-Mitchell B, Ochani M, Li J, Han J, Wang H, Yang H, Susarla S, Czura C, Mitchell R, Chen G, Sama A, Tracey KJ, Wang H: IFN-γ induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol 170:3890-3897, 2003.
21. Chaudry IH, Wichterman KA, Baue AE: Effect of sepsis on tissue adenine nucleotide levels. Surgery 85:205-211, 1979.
22. Qiu G, Wang C, Smith R, Harrison K, Yin K: Role of IFN-γ in bacterial containment in a model of intra-abdominal sepsis. Shock 16:425-429, 2001.
23. Palumbo R, Bianchi M: High mobility group box 1 protein, a cue for stem cell recruitment. Biochem Pharmacol 68:1165-1170, 2004.
24. Scaffidi P, Miteli T, Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195, 2002.
25. Reinhart K, Karzai W: Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit Care Med 29:8121-8125, 2001.
26. Opal SM, Fisher CJ, Dhainaut JF, Vincent JL, Erase R, Lowry SF, Sadoff JC, Slotman GJ, Levy H, Balk RA, Shelly MP, Pribble JP, LaBrecque JF, Lookabaugh J, Donovan H, Dubin H, Baughman R, Norman J, DeMaria E, Matzel K, Abraham E, Seneff M: Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med 25:1115-1124, 1997.
27. Moore TA, Perry ML, Getsoian AG, Newstead MW, Standiford TJ: Divergent role of γ interferon in a murine model of pulmonary versus systemic Klebsiella pneumoniae infection. Infect Immun 70:6310-6318, 2002.
28. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shock: a review of laboratory models and a proposal. J Surg Res 29:189-201, 1980.
29. Sheehan M, Wong HR, Hake PW, Zingarelli B: Parthenolide improves systemic hemodynamics and decreases tissue leukocyte sequestration in rats with polymicrobial sepsis. Crit Care Med 31:2263-2270, 2003.
30. Bustin M: Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 19:5237-5246, 1999.
31. Bianci ME, Beltrame M: Upwardly mobile proteins. Workshop: the role of HMG proteins in chromatin structure, gene expression and neoplasia. EMBO Rep 1:109-114, 2000.
32. Messmer D, Yang H, Telusma G, Knoll F, Li J, Messmer B, Tracey KJ, Chiorazzi N: High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol 173:307-313, 2004.
33. 1, interleukin-1β, and interleukin-4 in the heart. Am J Pathol 165:1883-1894, 2004.